Sharp John P 4
4 · PhaseBio Pharmaceuticals Inc · Filed Nov 3, 2021
Insider Transaction Report
Form 4
Sharp John P
CFO and Secretary
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2021-11-03$1.68/sh−7,500$12,600→ 90,582 totalExercise: $1.68From: 2020-04-11Exp: 2026-05-12→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock
2021-11-03$1.68/sh+7,500$12,600→ 57,724 total
Footnotes (1)
- [F1]All shares underlying this option have vested.